Table 2b.
Cancer incidence and mortality among men by diagnosis groups, Greenland, 1983–2014.
| Incidence |
Mortality |
|||||||
|---|---|---|---|---|---|---|---|---|
| Diagnosis groups | N | N (%) | ASR (W) | IRR (95% CI) | N | % | ASR (W) | MRR (95% CI) |
| Lip, oral cavity and pharynx | 224 | 9.5 | 25 | 3.0 (2.4–3.8) | 141 | 8.3 | 17 | 6.0 (4.1–8.6) |
| Respiratory organs | 683 | 29.0 | 89 | 2.3 (2.0–2.6) | 637 | 37.5 | 86 | 2.7 (2.3–3.1) |
| Gastrointestinal organs | 730 | 31.0 | 93 | 1.5 (1.4–1.7) | 520 | 30.6 | 70 | 1.8 (1.6–2.0) |
| Urinary tract | 137 | 5.8 | 17 | 0.6 (0.5–0.7) | 73 | 4.3 | 10 | 1.0 (0.8–1.3) |
| Male genital organs | 136 | 5.8 | 17 | 0.2 (0.2–0.2) | 42 | 2.5 | 7 | 0.3 (0.3–0.4) |
| Breast | 0 | 0.0 | 0 | 0.0 (0.0–0.0) | 0 | 0.0 | 0 | 0.0 (0.0–0.0) |
| Melanoma of skin | 15 | 0.6 | 2 | 0.1 (0.1–0.2) | 6 | 0.4 | 1 | 0.3 (0.2–0.4) |
| Lymphoma and leukaemia | 128 | 5.4 | 14 | 0.5 (0.4–0.6) | 59 | 3.5 | 7 | 0.6 (0.5–0.7) |
| Other specified sites | 134 | 5.7 | 15 | 0.8 (0.7–0.9) | 49 | 2.9 | 6 | 0.7 (0.5–0.9) |
| Unknown | 167 | 7.1 | 22 | 2.7 (2.1–3.5) | 172 | 10.1 | 26 | 3.9 (2.8–5.4) |
| Total | 2354 | 100.0 | 292 | 1.0 (1.0–1.1) | 1699 | 100.0 | 229 | 1.7 (1.6–1.8) |
N = Numbers of cancer incidence and mortality.
N (%) = the percentage of the numbers of cancer incidence and mortality.
ASR (W) = Age standardized rates for the world, per 100,000 person years.
IRR: Incidence rate-ratios, with 95% confidence intervals, relative to the rates in the other Nordic countries.
MRR: Mortality rate-ratios, with 95% confidence intervals, relative to the rates in the other Nordic countries.
95% CI: 95% confidence intervals.